Data / Form D filings / Incannex Healthcare Inc.
Incannex Healthcare Inc.: Form D filing
Incannex Healthcare Inc., a pharmaceuticals company in Norwest Nsw, Australia, filed a Form D with the SEC in 2025. The latest, on March 17, 2025, reports $12.5 million sold of a $12.5 million offering to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 8 CENTURY CIRCUIT, STE 105, Norwest Nsw, Australia, 2153
- Phone
- 61 409 840 786
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1873875
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 17, 2025 | New notice | $12,499,825 | $12,499,825 | 7 | Mar 10, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| JOEL LATHAM | Executive Officer, Director | |
| JOSEPH SWAN | Executive Officer | |
| LEKHRAM M. CHANGOER | Executive Officer | |
| LUIGI M. BARBATO | Executive Officer | |
| ROBERT M. CLARK | Director | |
| GEORGE M. ANASTASSOV | Director | |
| PETER M. WIDDOWS | Director | |
| TROY M. VALENTINE | Director |
Every Form D from the week of Mar 17, 2025 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Incannex Healthcare Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.